transparent
Expression Analysis
   
Transparent
Client Login        Register
     Username   Password      
Top blue bar
Services Bar divider Quality Bar divider Clinical Trials Bar divider Leadership Bar divider Resources Bar divider About Us Bar divider Contact Us Bar divider Homepage
Blue bar bottom
In this section
Introduction
Technical Notes
Posters & Presentations
Publications
Upcoming Events
Press Releases
e-Newsletter

 

Contact Us! Toll Free 866.293.6094
Graphic element
 

 

 
 
RESOURCES

Press Releases

 
 

FOR IMMEDIATE RELEASE

Contact:
Jim Parina
724-935-7029
jparina@expressionanalysis.com



Expression Analysis lands $1.5M EPA deal

June 3, 2003

Sabine Vollmer

Expression Analysis, a microarray genetics testing and analysis company that spun out of Duke University in September 2001, has received a three-year contract from the Environmental Protection Agency worth up to $1.5 million, or about as much as the startup's first-year revenue.

To fulfill the EPA contract, Expression Analysis will run gene expression analyses. But the EPA has not disclosed how it will use the results of the tests, says Steve Casey, the company's co-founder and chief operating officer.

Since its inception, Expression Analysis has grown to 13 employees and assembled a client list of 72. Entrepreneur magazine, in its June issue, ranks the company 88th among its 100 fastest growing startups in the United States.

Casey attributed the company's fast paced start to turning a Master of Business Administration homework assignment and a highly marketable idea into reality through a committed focus on quality and customer service.

Expression Analysis was co-founded by Casey and Don Holzworth, chief executive officer of Durham-based Constella Group, with a $1.2 million investment.

About Expression Analysis
Expression Analysis, Inc., (EA) (www.expressionanalysis.com) is a full-service microarray genomics testing and analysis organization dedicated to providing clients with the highest quality genomic processing and data analysis services using Affymetrix GeneChip® brand technology. In 2004, EA became the first microarray services facility, worldwide, to provide GLP-compliant services. EA is a U.S.-based authorized service provider for Affymetrix (www.affymetrix.com), a California-based company that develops and commercializes systems to help researchers explore the relationship between genes and human health.

 

 
transparent© 2006 Expression Analysis—All rights reserved. transparentContact ustransparent Site map